Biotest AG VZ Stock
Your prediction
Pros and Cons of Biotest AG VZ in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biotest AG VZ vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biotest AG VZ | - | - | - | - | - | - | - |
| MPH Health Care AG | 1.340% | 2.752% | -7.819% | -4.274% | 2.283% | 40.439% | -11.811% |
| Pacira Pharmaceuticals | - | 7.650% | 11.299% | -17.917% | -8.796% | -47.884% | -68.226% |
| Rockwell Medical Inc. | -2.530% | -4.309% | -14.549% | -51.583% | 19.808% | -61.034% | -94.244% |
News
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.